Compared side by side
Ipamorelin vs hexarelin: how they differ
The short answer
Both release growth hormone through the ghrelin receptor: hexarelin gives some of the largest GH spikes, but with daily use the response drops partly over weeks and recovers after a break, while ipamorelin releases GH without raising cortisol in animal studies. In rats, hexarelin also protected the heart through a pathway independent of GH. Ipamorelin is commonly run 8–12 weeks on and 4 weeks off, and hexarelin in shorter cycles of 4–6 weeks.
Side by side
| Compared | Ipamorelin | Hexarelin |
|---|---|---|
| Category | Growth hormone | Growth hormone |
| Also known as | IPAM | Examorelin |
| What it is | Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides. | One of the most powerful GH secretagogues, with a catch: the response fades. |
| How it works | Selective growth hormone secretagogue and ghrelin receptor agonist. In animal studies it released GH without raising cortisol or ACTH, and users report milder hunger than with GHRP-6. Considered one of the cleanest GH pulses available. | One of the most potent GHRPs (on par with GHRP-2 in humans). Strongly stimulates GH release, and in rat studies it protected heart muscle independently of GH. The GH response fades partly within weeks of ongoing use and recovers after a break — cycle carefully. |
| Commonly reported | Deeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. Its human data are a small GH study and phase 2 trials in surgical patients; it was never approved. | A strong effect at first, flushing or a head rush after injecting, and water retention with some hunger (less than GHRP-6). In rats it also protected the heart through a pathway independent of GH. |
| Studied range | Research range: 200–300 mcg, starting dose 200 mcg. Studied in research — not a recommendation. | Research range: 100–200 mcg. Studied in research — not a recommendation. |
| How often | 2–3x daily, best fasted or before bed | 2–3x daily |
| Half-life | ~2 hours (measured in healthy men, given IV) | ~55–70 min (community estimate; not measured in people: in rats it lasted ~76 minutes, in dogs ~2 hours) |
| Route | SubQ injection, IM injection | SubQ injection |
| Typical run | Commonly 8–12 weeks on, 4 weeks off to avoid receptor desensitisation. Some run longer with breaks. | Community protocols keep cycles short (4–6 weeks) because the GH response fades partly with ongoing use; in a 16-week study it recovered after 4 weeks off. Always cycle off. |
| Evidence | Moderate: animal studies + some human data | Moderate: animal studies + some human data |
| Common side effects | Headache, flushing, nausea, water retention, numbness/tingling | Cortisol elevation, prolactin increase, water retention, fatigue, desensitization with chronic use |
- Category
- IpamorelinGrowth hormone
- HexarelinGrowth hormone
- Also known as
- IpamorelinIPAM
- HexarelinExamorelin
- What it is
- IpamorelinConsidered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.
- HexarelinOne of the most powerful GH secretagogues, with a catch: the response fades.
- How it works
- IpamorelinSelective growth hormone secretagogue and ghrelin receptor agonist. In animal studies it released GH without raising cortisol or ACTH, and users report milder hunger than with GHRP-6. Considered one of the cleanest GH pulses available.
- HexarelinOne of the most potent GHRPs (on par with GHRP-2 in humans). Strongly stimulates GH release, and in rat studies it protected heart muscle independently of GH. The GH response fades partly within weeks of ongoing use and recovers after a break — cycle carefully.
- Commonly reported
- IpamorelinDeeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. Its human data are a small GH study and phase 2 trials in surgical patients; it was never approved.
- HexarelinA strong effect at first, flushing or a head rush after injecting, and water retention with some hunger (less than GHRP-6). In rats it also protected the heart through a pathway independent of GH.
- Studied range
- IpamorelinResearch range: 200–300 mcg, starting dose 200 mcg. Studied in research — not a recommendation.
- HexarelinResearch range: 100–200 mcg. Studied in research — not a recommendation.
- How often
- Ipamorelin2–3x daily, best fasted or before bed
- Hexarelin2–3x daily
- Half-life
- Ipamorelin~2 hours (measured in healthy men, given IV)
- Hexarelin~55–70 min (community estimate; not measured in people: in rats it lasted ~76 minutes, in dogs ~2 hours)
- Route
- IpamorelinSubQ injection, IM injection
- HexarelinSubQ injection
- Typical run
- IpamorelinCommonly 8–12 weeks on, 4 weeks off to avoid receptor desensitisation. Some run longer with breaks.
- HexarelinCommunity protocols keep cycles short (4–6 weeks) because the GH response fades partly with ongoing use; in a 16-week study it recovered after 4 weeks off. Always cycle off.
- Evidence
- IpamorelinModerate: animal studies + some human data
- HexarelinModerate: animal studies + some human data
- Common side effects
- IpamorelinHeadache, flushing, nausea, water retention, numbness/tingling
- HexarelinCortisol elevation, prolactin increase, water retention, fatigue, desensitization with chronic use
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Ipamorelin
- Day 1–14 Sleep is deepening
- Day 14–28 Recovery is noticeably faster
- Day 28–56 Body composition shifts showing up
- Day 56–84 Cycle-end + planned break
Hexarelin
- Day 1–7 A strong GH pulse from week one
- Day 7–28 Productive window — but watch the clock
- Day 28–42 Time to cycle off
Questions people ask
How long do ipamorelin and hexarelin last?
The half-life of ipamorelin is ~2 hours (measured in healthy men, given IV). The half-life of hexarelin is ~55–70 min (community estimate; not measured in people: in rats it lasted ~76 minutes, in dogs ~2 hours).
How often are ipamorelin and hexarelin taken?
Ipamorelin: 2–3x daily, best fasted or before bed. Routes: SubQ injection, IM injection. Hexarelin: 2–3x daily. Route: SubQ injection.
How are ipamorelin and hexarelin dosed in research?
The research range for ipamorelin is 200–300 mcg, with a 200 mcg starting dose. The research range for hexarelin is 100–200 mcg. Studied in research — not a recommendation.
What are the common side effects of ipamorelin and hexarelin?
For ipamorelin, the library lists: headache, flushing, nausea, water retention, numbness/tingling. For hexarelin: cortisol elevation, prolactin increase, water retention, fatigue, desensitization with chronic use.